Barone W, Jerome B, Michiko MW, Perl P (2019) Perceived benefits of MDMA-assisted psychotherapy beyond symptom reduction: qualitative follow-up study of a clinical trial for individuals with treatment-resistant PTSD. J Psychoactive Drugs 51(2):199–208. https://doi.org/10.1080/02791072.2019.1580805
Baslam A, Aitbaba A, Hanchi AL, Tazart Z, Aboufatima R, Soraa N, Ait-El-Mokhtar M, Boussaa S, Baslam M, Chait A (2023) Modulation of gut microbiome in ecstasy/MDMA-induced behavioral and biochemical impairment in rats and potential of post-treatment with Anacyclus pyrethrum L. aqueous extract to mitigate adverse effects. Int J Mol Sci. https://doi.org/10.3390/ijms24109086
Article PubMed PubMed Central Google Scholar
Baumann MH, Clark RD, Rothman RB (2008) Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol Biochem Behav 90(2):208–217. https://doi.org/10.1016/j.pbb.2008.02.018
Article CAS PubMed PubMed Central Google Scholar
Baumann MH, Wang X, Rothman RB (2007) 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 189(4):407–424. https://doi.org/10.1007/s00213-006-0322-6
Article CAS PubMed Google Scholar
Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA (2009) Effects of dose and route of administration on pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos 37(11):2163–2170. https://doi.org/10.1124/dmd.109.028506
Article CAS PubMed PubMed Central Google Scholar
Berrio JP, Hestehave S, Kalliokoski O (2024) Reliability of sucrose preference testing following short or no food and water deprivation—a systematic review and meta-analysis of rat models of chronic unpredictable stress. Transl Psychiatry 14(1):39. https://doi.org/10.1038/s41398-024-02742-0
Article PubMed PubMed Central Google Scholar
Biezonski DK, Meyer JS (2010) Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem 112(4):951–962. https://doi.org/10.1111/j.1471-4159.2009.06515.x
Article CAS PubMed Google Scholar
Carlsson M, Carlsson A (1988) A regional study of sex differences in rat brain serotonin. Prog Neuropsychopharmacol Biol Psychiatry 12(1):53–61. https://doi.org/10.1016/0278-5846(88)90061-9
Article CAS PubMed Google Scholar
Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA (2014) Nonlinear pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metab Dispos 42(1):119–125. https://doi.org/10.1124/dmd.113.053678
Article CAS PubMed Google Scholar
Conductier G, Crosson C, Hen R, Bockaert J, Compan V (2005) 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221. Neuropsychopharmacology 30(6):1056–1063. https://doi.org/10.1038/sj.npp.1300662
Article CAS PubMed Google Scholar
Connor TJ, McNamara MG, Finn D, Currid A, O’Malley M, Redmond AM, Kelly JP, Leonard BE (1998) Acute 3,4-methylenedioxymethamphetamine (MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology 38(3):253–260. https://doi.org/10.1016/S0162-3109(97)00084-2
Article CAS PubMed Google Scholar
Cox BM, Shah MM, Cichon T, Tancer ME, Galloway MP, Thomas DM, Perrine SA (2014) Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat. Prog Neuropsychopharmacol Biol Psychiatry 48:229–235. https://doi.org/10.1016/j.pnpbp.2013.09.021
Article CAS PubMed Google Scholar
Davidson CJ, Svenson DW, Hannigan JH, Perrine SA, Bowen SE (2022) A novel preclinical model of environment-like combined benzene, toluene, ethylbenzene, and xylenes (BTEX) exposure: behavioral and neurochemical findings. Neurotoxicol Teratol 91:107076. https://doi.org/10.1016/j.ntt.2022.107076
Article CAS PubMed Google Scholar
Davison D, Parrott AC (1997) Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects. Hum Psychopharmacol Clin Exp 12(3):221–226. https://doi.org/10.1002/(sici)1099-1077(199705/06)12:3%3C;221::Aidhup854%3E;3.0.Co;2-c
Duchesne A, Dufresne MM, Sullivan RM (2009) Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling. Prog Neuropsychopharmacol Biol Psychiatry 33(2):251–261. https://doi.org/10.1016/j.pnpbp.2008.11.012
Article CAS PubMed Google Scholar
Elsey JWB, Wuestman VAF, Fieten A (2025) User perceptions of long-term costs and benefits of MDMA use: findings from a large online sample. Drugs Educ Prev Policy 32(1):29–41. https://doi.org/10.1080/09687637.2023.2284643
Feduccia AA, Jerome L, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R (2019) Breakthrough for trauma treatment: safety and efficacy of MDMA-Assisted psychotherapy compared to Paroxetine and Sertraline [Review]. Front Psychiatry 10. https://doi.org/10.3389/fpsyt.2019.00650
Felton TM, Auerbach SB (2004) Changes in [gamma]-aminobutyric acid tone and extracellular serotonin in the dorsal raphe nucleus over the rat estrous cycle. Neuroendocrinology 80(3):152–157. https://doi.org/10.1159/000082356
Article CAS PubMed Google Scholar
Ferraz-de-Paula V, Stankevicius D, Ribeiro A, Pinheiro ML, Rodrigues-Costa EC, Florio JC, Lapachinske SF, Moreau RLM, Palermo-Neto J (2011) Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice. Braz J Med Biol Res 44:428–437. https://doi.org/10.1590/S0100-879X2011007500046
Article CAS PubMed Google Scholar
Gaulden AD, Burson N, Sadik N, Ghosh I, Khan SJ, Brummelte S, Kallakuri S, Perrine SA (2021) Effects of fentanyl on acute locomotor activity, behavioral sensitization, and contextual reward in female and male rats. Drug Alcohol Depend 229:109101. https://doi.org/10.1016/j.drugalcdep.2021.109101
Article CAS PubMed PubMed Central Google Scholar
Gheidi A, Davidson CJ, Simpson SC, Yahya MA, Sadik N, Mascarin AT, Perrine SA (2023) Norepinephrine depletion in the brain sex-dependently modulates aspects of spatial learning and memory in female and male rats. Psychopharmacology 240(12):2585–2595. https://doi.org/10.1007/s00213-023-06453-0
Article CAS PubMed PubMed Central Google Scholar
Gold MS, Blum K, Febo M, Baron D, Modestino EJ, Elman I, Badgaiyan RD (2018) Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems. Front Bioscience-Scholar 10(2):309–325. https://doi.org/10.2741/s518
Green AR, Mechan AO, Elliott JM, O’Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Pharmacol Rev 55(3):463–508. https://doi.org/10.1124/pr.55.3.3
Article CAS PubMed Google Scholar
Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS (2002) Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur J Pharmacol 446(1):89–96. https://doi.org/10.1016/S0014-2999(02)01820-4
Article CAS PubMed Google Scholar
Ho YJ, Pawlak CR, Guo L, Schwarting RKW (2004) Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav Brain Res 149(2):135–144. https://doi.org/10.1016/S0166-4328(03)00220-1
Article CAS PubMed Google Scholar
Hu C, Luo Y, Wang H, Kuang S, Liang G, Yang Y, Mai S, Yang J (2017) Re-evaluation of the interrelationships among the behavioral tests in rats exposed to chronic unpredictable mild stress. PLoS ONE 12(9):e0185129. https://doi.org/10.1371/journal.pone.0185129
Article CAS PubMed PubMed Central Google Scholar
Karimi S, Jahanshahi M, Golalipour MJ (2014) The effect of MDMA-induced anxiety on neuronal apoptosis in adult male rats’ hippocampus. Folia Biol (Praha) 60(4):187–191. https://doi.org/10.14712/fb2014060040187
Comments (0)